Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2003
03/27/2003WO2003024992A2 HUMAN AND MOUSE β-DEFENSINS, ANTIMICROBIAL PEPTIDES
03/27/2003WO2003024991A2 Tall-1 receptor molecules and uses thereof
03/27/2003WO2003024990A2 Variants of corticotropin releasing hormone receptor type 1 and uses thereof
03/27/2003WO2003024988A1 Antisense modulation of nac expression
03/27/2003WO2003024987A1 Antisense modulation of fibroblast growth factor receptor 2 expression
03/27/2003WO2003024940A1 Bifunctional chelating agent for actinium
03/27/2003WO2003024932A1 Bis-amino acid sulfonamides as hiv protease inhibitors
03/27/2003WO2003024924A1 Novel compounds and compositions as cathepsin inhibitors
03/27/2003WO2003024486A1 Remedies for bone loss
03/27/2003WO2003024481A2 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
03/27/2003WO2003024479A1 Enamel matrix protein compositions for modulating immune response
03/27/2003WO2003024478A1 Treatment of central nervous system disorders by use of pdgf or vegf
03/27/2003WO2003024476A1 The use of lactogenic and somatogenic hormones to enhance reproductive efficiency in mammals
03/27/2003WO2003024475A1 Water-insoluble sustained release compositions, preparations thereof and process for producing the same
03/27/2003WO2003024474A2 Anti-inflammatory agent
03/27/2003WO2003024472A2 Prolactin induced increase in neutral stem cell numbers and therapeutical use thereof
03/27/2003WO2003024471A2 Effect of growth hormone and igf-1 on neural stem cells and therapeutic application
03/27/2003WO2003024461A1 Hcv combination therapy
03/27/2003WO2003024459A1 Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents
03/27/2003WO2003024425A1 Nanoparticulate insulin formulations
03/27/2003WO2003024422A1 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities
03/27/2003WO2003024419A2 Apoptosis-mimicking natural vesicles and use thereof in medical treatment
03/27/2003WO2003024410A2 Composition for treating streptococcus pneumoniae
03/27/2003WO2003024409A2 Q4n2neg2 enhances cftr activity
03/27/2003WO2003024404A2 Chemokines as adjuvants of immune response
03/27/2003WO2003024398A2 Treatment of sepsis with tafi
03/27/2003WO2003024389A2 T. reesei phytase enyzmes, polynucleides encoding the enzymes, vectors and host cells thereof, and methods of using
03/27/2003WO2003024387A2 Method and pharmaceutical composition for treating inflammation
03/27/2003WO2003024384A2 Improved methods for treatment with viral vectors
03/27/2003WO2003024357A2 Microfabricated nanopore device for sustained release of therapeutic agent
03/27/2003WO2003024354A2 Interleukin-12 as a veterinary vaccine adjuvant
03/27/2003WO2003024246A1 Compositions for appetite control and related methods
03/27/2003WO2003000843A3 P53 binding protein-related protein in cardiomyopathy
03/27/2003WO2002098356A3 Ppp2cs as modifiers of the p53 pathway and methods of use
03/27/2003WO2002096358A3 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
03/27/2003WO2002092837A9 Nucleic and molecule associated with prostate cancer and melanoma immunodetection and immunotherapy
03/27/2003WO2002090551A3 Self-containing lactococcus strain
03/27/2003WO2002090525A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/27/2003WO2002087496A3 Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling
03/27/2003WO2002079227A8 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/27/2003WO2002078607A3 Mucin peptide with immunoenhancing properties
03/27/2003WO2002077193A8 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
03/27/2003WO2002072785A3 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
03/27/2003WO2002070691A3 Abcg4 transporter and uses thereof
03/27/2003WO2002064733A3 Protein-protein interactions
03/27/2003WO2002062377A3 Combined use of factor vii polypeptides and factor viii polypeptides
03/27/2003WO2002062319A3 Microsphere delivery of mucin peptides
03/27/2003WO2002059291A3 Biological organism for preparing pharmaceutical compositions for treating mammals
03/27/2003WO2002058534A8 Compositions and methods for the therapy and diagnosis of colon cancer
03/27/2003WO2002056829A3 Methods for preparing purified daptomycin
03/27/2003WO2002055544A3 Fibrin binding polypeptides useful inter alia in medical imaging processes
03/27/2003WO2002055100A3 Method and composition for inhibition of tumor growth and enhancing an immune response
03/27/2003WO2002053717A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/27/2003WO2002053190A3 Particles for inhalation having sustained release properties
03/27/2003WO2002053100A3 Pharmaceutical dosage form for oral administration of low molecular weight heparin
03/27/2003WO2002052019A3 22437, a human sulfatase and uses therefor
03/27/2003WO2002048157A3 Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors
03/27/2003WO2002047705A3 Compositions containing an active fraction isolated from tricholoma conglobatum and methods of use
03/27/2003WO2002044374A3 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
03/27/2003WO2002040508A3 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release
03/27/2003WO2002040506A3 Modified clostridial neurotoxins with altered biological persistence
03/27/2003WO2002038170A3 Stabilized inteferon compositions
03/27/2003WO2002034782A8 Endozepine-like polypeptide nov1 and nucleic acid encoding the same
03/27/2003WO2002034205B1 Using heat shock proteins to increase immune response
03/27/2003WO2002034201A3 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy
03/27/2003WO2002031512A3 Molecular interactions in hematopoietic cells
03/27/2003WO2002031141A3 Antisense oligonucleotide directed toward mammalian vegf receptor genes and uses thereof
03/27/2003WO2002029060A3 Hematopoietin receptors hpr1 and hpr2
03/27/2003WO2002026985A3 G-protein coupled recptors
03/27/2003WO2002026951A3 Oxidoreductases
03/27/2003WO2002026774A3 Melanocortin receptor ligands
03/27/2003WO2002024741A3 Isolated genomic polynucleotide fragments from chromosome 7
03/27/2003WO2002022817A3 Nuclear receptor l66 and methods of use
03/27/2003WO2002022684A3 Transporters and ion channels
03/27/2003WO2002019999A3 Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant
03/27/2003WO2002018954A9 Inhibition of cmv infection and dissemination
03/27/2003WO2002018573A3 54370, a novel human sulfate transporter and uses therefor
03/27/2003WO2002016585A3 Imidazoline receptor homologs
03/27/2003WO2002016419A9 Progression suppressed gene 13 (psgen 13) and uses thereof
03/27/2003WO2002012340A3 Transporters and ion channels
03/27/2003WO2002011667A3 Pharmaceutical compositions and methods useful for modulating angiogenesis
03/27/2003WO2002006329A3 Human polynucleotides and polypeptides encoded thereby
03/27/2003WO2002005857A3 Phosphatonin-related gene and methods of use thereof
03/27/2003WO2001098520A8 Transgenically produced platelet derived growth factor
03/27/2003WO2001079557A3 Gtp-binding protein useful in treatment and detection of cancer
03/27/2003US20030060624 Reacting 2-chloro-4- trifluoromethyl-phenyl)-acetonitrile in the presence of a palladium catalyst and a base to form indene derivative
03/27/2003US20030060619 Antibody for use in the disgnosis and treatment of kidney, urogenital, and sex disorders
03/27/2003US20030060616 Type II IL-1 receptors
03/27/2003US20030060615 Novel Bak binding protein, DNA encoding the protein, and methods of use thereof
03/27/2003US20030060614 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
03/27/2003US20030060613 Protein for use in the treatment of bone, tumor and inflammatory disorders
03/27/2003US20030060611 Method and reagent for the inhibition of NOGO gene
03/27/2003US20030060606 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
03/27/2003US20030060605 Polypeptide for use in the treatment of tumors, autoimmune, inflammatory and viral diseases
03/27/2003US20030060604 Apolipoprotein agonist for use in the treatment of dyslipidemia
03/27/2003US20030060602 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060601 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060600 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060599 For therapy and prophylaxis of viral infection, such as HIV infection
03/27/2003US20030060598 Glycopeptide derivatives and pharmaceutical compositions containing the same
1 ... 1877 1878 1879 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 ... 3163